Details for New Drug Application (NDA): 010251
✉ Email this page to a colleague
NDA 010251 describes INVERSINE, which is a drug marketed by Targacept and is included in one NDA. Additional details are available on the INVERSINE profile page.
The generic ingredient in INVERSINE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.
The generic ingredient in INVERSINE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.
Summary for 010251
| Tradename: | INVERSINE |
| Applicant: | Targacept |
| Ingredient: | mecamylamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 010251
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
